{"id":17937,"date":"2026-07-31T15:14:51","date_gmt":"2026-07-31T07:14:51","guid":{"rendered":"https:\/\/y2nbc5qg9c-staging.wpdns.site\/new-drug-development-and-regulation\/"},"modified":"2026-11-01T09:36:37","modified_gmt":"2026-11-01T01:36:37","slug":"new-drug-development-and-regulation","status":"publish","type":"page","link":"https:\/\/u-neuron.com\/en\/news-updates\/new-drug-development-and-regulation\/","title":{"rendered":"\u6c38\u7acb\u69ae\u7f8a\u6c34\u5e79\u7d30\u80de\u65b0\u85e5 \u7372\u518d\u751f\u91ab\u7642\u96d9\u91cd\u5feb\u901f\u901a\u95dc\u8a8d\u8b49\u6c38\u7acb\u69ae (6973-TW) \u4eca (22) \u65e5\u5ba3\u5e03\uff0c\u65d7\u4e0b\u6cbb\u7642\u52c3\u8d77\u529f\u80fd\u969c\u7919\u65b0\u85e5 UA002\uff0c\u7372\u5f97\u885b\u798f\u90e8 TFDA \u6838\u51c6\u7d0d\u5165\u300c\u85e5\u54c1\u5c08\u6848\u8aee\u8a62\u8f14\u5c0e\u6848\u4ef6\u300d\uff0c\u4e26\u540c\u6b65\u53d6\u5f97\u8ca1\u5718\u6cd5\u4eba\u85e5\u54c1\u67e5\u9a57\u4e2d\u5fc3 CDE\u300c\u6307\u6a19\u6848\u4ef6\u300d\u8cc7\u683c\uff0c\u672a\u4f86\u5c07\u5728\u5c08\u6848\u8f14\u5c0e\u6a5f\u5236\u4e0b\uff0c\u53ef\u671b\u52a0\u901f\u958b\u767c\u8207\u5be9\u67e5\u6d41\u7a0b\u3001\u964d\u4f4e\u958b\u767c\u6d41\u7a0b\uff0c\u5982\u540c\u53d6\u5f97\u518d\u751f\u91ab\u7642\u5e02\u5834\u7684\u96d9\u91cd\u5feb\u901f\u901a\u95dc\u8a8d\u8b49\u3002 \u6c38\u7acb\u69ae\u7f8a\u6c34\u5e79\u7d30\u80de\u65b0\u85e5\uff0c\u7372\u518d\u751f\u91ab\u7642\u96d9\u91cd\u5feb\u901f\u901a\u95dc\u8a8d\u8b49\u3002(\u5716\uff1ashutterstock) \u6c38\u7acb\u69ae\u6307\u51fa\uff0cUA002 \u70ba\u81ea\u884c\u7814\u767c\u7684\u7f8a\u6c34\u5e79\u7d30\u80de\u65b0\u85e5\uff0c\u5df2\u5b8c\u6210\u81e8\u5e8a\u4e00\u671f\u7684\u6536\u6848\uff0c\u4e5f\u5df2\u9a57\u8b49 UA002 \u7684\u5b89\u5168\u6027\u8207\u521d\u6b65\u7642\u6548\uff0c\u76ee\u524d\u6b63\u5728\u9032\u884c\u81e8\u5e8a 2a \u8a66\u9a57\u3002  \u6c38\u7acb\u69ae\u8aaa\u660e\uff0c\u6839\u64da TFDA\u300c\u85e5\u54c1\u5c08\u6848\u8aee\u8a62\u8f14\u5c0e\u6848\u4ef6\u300d\u53ca CDE\u300c\u6307\u6a19\u6848\u4ef6\u300d\u8f14\u5c0e\u6a5f\u5236\uff0c\u4e3b\u7ba1\u6a5f\u95dc\u5c07\u900f\u904e\u5c08\u5247\u7a97\u53e3\uff0c\u63d0\u4f9b\u5f9e\u6cd5\u898f\u7b56\u7565\u3001\u81e8\u5e8a\u8a66\u9a57\u8a2d\u8a08\u3001\u88fd\u9020\u8207\u54c1\u8cea\u7ba1\u5236\uff0c\u5230\u4e0a\u5e02\u7533\u8acb\u7684\u4e00\u7ad9\u5f0f\u8f14\u5c0e\u670d\u52d9\uff0c\u53ef\u5927\u5e45\u7e2e\u77ed\u85e5\u54c1\u958b\u767c\u8207\u5be9\u67e5\u6642\u7a0b\uff0c\u540c\u6642\u964d\u4f4e\u958b\u767c\u6210\u672c\u3002 \u6c38\u7acb\u69ae\u9032\u4e00\u6b65\u9ede\u51fa\uff0cTFDA\u300c\u85e5\u54c1\u5c08\u6848\u8aee\u8a62\u8f14\u5c0e\u8981\u9ede\u300d\u5df2\u5728\u4eca\u5e74\u5b8c\u6210\u4fee\u6b63\uff0c\u6b63\u5f0f\u5c07\u518d\u751f\u91ab\u7642\u88fd\u5291\u7d0d\u5165\u9069\u7528\u7bc4\u7587\uff0c\u63d0\u4f9b\u660e\u78ba\u6cd5\u898f\u8207\u5be9\u67e5\u8f14\u5c0e\u4f9d\u5faa\u3002 \u71df\u904b\u9577\u838a\u6b23\u6021\u8868\u793a\uff0c\u6839\u64da\u518d\u751f\u91ab\u7642\u96d9\u6cd5\uff0c\u5c07\u7a4d\u6975\u8207\u4e3b\u7ba1\u6a5f\u95dc\u5bc6\u5207\u5408\u4f5c\uff0c\u4ee5\u6709\u6548\u7387\u7684\u958b\u767c\u8def\u5f91\u63a8\u9032 UA002 \u9032\u7a0b\u3002 \u8463\u4e8b\u9577\u7c21\u5949\u4efb\u5247\u6307\u51fa\uff0c\u518d\u751f\u91ab\u7642\u96d9\u6cd5\u5373\u5c07\u4e0a\u8def\uff0c\u5c0d\u65bc\u7522\u696d\u800c\u8a00\u662f\u4e00\u5927\u6fc0\u52f5\uff0c\u4f46\u5be6\u65bd\u521d\u671f\u9700\u8981\u4e3b\u7ba1\u6a5f\u95dc\u660e\u78ba\u6307\u5f15\uff0c\u56e0\u6b64 UA002 \u7372 TFDA \u8207 CDE \u5c08\u6848\u8f14\u5c0e\uff0c\u5728\u4e3b\u7ba1\u6a5f\u95dc\u5354\u52a9\u4e0b\uff0c\u96c6\u4e2d\u8cc7\u6e90\u52a0\u901f\u7814\u767c\u8207\u4e0a\u5e02\u9032\u7a0b\u3002 \u81f3\u65bc\u5e02\u5834\u73fe\u6cc1\uff0c\u6839\u64da\u5e02\u5834\u7814\u7a76\u6a5f\u69cb Global Markets Insights \u5831\u544a\u6307\u51fa\uff0c\u5168\u7403\u52c3\u8d77\u529f\u80fd\u969c\u7919\u85e5\u7269\u81ea 2025 \u5e74\u8d77\uff0c\u9810\u4f30\u5e74\u8907\u5408\u6210\u9577\u7387 (CAGR) \u9054 9.2%\uff0c\u81f3 2034 \u5e74\u5e02\u5834\u898f\u6a21\u4e0a\u770b 70 \u5104\u5143\u3002"},"content":{"rendered":"<div class=\"wpb-content-wrapper\" id=\"wpb-content-root\"><p>[vc_section woodmart_stretch_content=&#8221;section-stretch-content&#8221; css=&#8221;.vc_custom_1769600714167{margin-top: -70px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}&#8221; woodmart_css_id=&#8221;6979f6af2f435&#8243; responsive_spacing=&#8221;eyJwYXJhbV90eXBlIjoid29vZG1hcnRfcmVzcG9uc2l2ZV9zcGFjaW5nIiwic2VsZWN0b3JfaWQiOiI2OTc5ZjZhZjJmNDM1Iiwic2hvcnRjb2RlIjoidmNfc2VjdGlvbiIsImRhdGEiOnsidGFibGV0Ijp7fSwibW9iaWxlIjp7fX19&#8243; mobile_bg_img_hidden=&#8221;no&#8221; tablet_bg_img_hidden=&#8221;no&#8221; woodmart_parallax=&#8221;0&#8243; woodmart_gradient_switch=&#8221;no&#8221; woodmart_box_shadow=&#8221;no&#8221; wd_z_index=&#8221;no&#8221; woodmart_disable_overflow=&#8221;0&#8243;][vc_row css=&#8221;.vc_custom_1785481912965{padding-top: 120px !important;padding-bottom: 90px !important;background-image: url(https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/07\/0-Science-Microscopic-1920&#215;1080-1.png?id=17612) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221; woodmart_css_id=&#8221;6a6c4a9be9b98&#8243; responsive_spacing=&#8221;eyJwYXJhbV90eXBlIjoid29vZG1hcnRfcmVzcG9uc2l2ZV9zcGFjaW5nIiwic2VsZWN0b3JfaWQiOiI2YTZjNGE5YmU5Yjk4Iiwic2hvcnRjb2RlIjoidmNfcm93IiwiZGF0YSI6eyJ0YWJsZXQiOnt9LCJtb2JpbGUiOnt9fX0=&#8221; mobile_bg_img_hidden=&#8221;no&#8221; tablet_bg_img_hidden=&#8221;no&#8221; woodmart_parallax=&#8221;0&#8243; woodmart_gradient_switch=&#8221;yes&#8221; woodmart_box_shadow=&#8221;no&#8221; wd_z_index=&#8221;no&#8221; woodmart_disable_overflow=&#8221;0&#8243; row_reverse_mobile=&#8221;0&#8243; row_reverse_tablet=&#8221;0&#8243; woodmart_color_gradient=&#8221;rgba(11, 14, 33, 0)-0\/rgb(11, 14, 33)-100\/|linear-gradient(top , rgba(11, 14, 33, 0) , rgb(11, 14, 33) 100%)|linear|top&#8221;][vc_column]\n\t\t<div id=\"wd-6ae6975085578\" class=\"title-wrapper wd-wpb wd-set-mb reset-last-child  wd-animation wd-transform wd-animation-top-flip-x wd-animation-slow wd_delay_200 wd-rs-6ae6975085578 wd-title-color-white wd-title-style-default text-center  wd-underline-colored\">\n\t\t\t\n\t\t\t<div class=\"liner-continer\">\n\t\t\t\t<h4 class=\"woodmart-title-container title  wd-font-weight- wd-fontsize-xxxl\" >Drug Development & Regulatory Affairs<\/h4>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\n\t\t\t\n\t\t\t\n\t\t<\/div>\n\t\t\n\t\t[\/vc_column][\/vc_row][\/vc_section][vc_section css=&#8221;.vc_custom_1769601154857{padding-top: 60px !important;}&#8221; woodmart_css_id=&#8221;6979f87423839&#8243; responsive_spacing=&#8221;eyJwYXJhbV90eXBlIjoid29vZG1hcnRfcmVzcG9uc2l2ZV9zcGFjaW5nIiwic2VsZWN0b3JfaWQiOiI2OTc5Zjg3NDIzODM5Iiwic2hvcnRjb2RlIjoidmNfc2VjdGlvbiIsImRhdGEiOnsidGFibGV0Ijp7fSwibW9iaWxlIjp7InBhZGRpbmctcmlnaHQiOiIzMCIsInBhZGRpbmctbGVmdCI6IjMwIn19fQ==&#8221; mobile_bg_img_hidden=&#8221;no&#8221; tablet_bg_img_hidden=&#8221;no&#8221; woodmart_parallax=&#8221;0&#8243; woodmart_gradient_switch=&#8221;no&#8221; woodmart_box_shadow=&#8221;no&#8221; wd_z_index=&#8221;no&#8221; woodmart_disable_overflow=&#8221;0&#8243;][vc_row gap=&#8221;35&#8243; woodmart_css_id=&#8221;6979f884c9974&#8243; responsive_spacing=&#8221;eyJwYXJhbV90eXBlIjoid29vZG1hcnRfcmVzcG9uc2l2ZV9zcGFjaW5nIiwic2VsZWN0b3JfaWQiOiI2OTc5Zjg4NGM5OTc0Iiwic2hvcnRjb2RlIjoidmNfcm93IiwiZGF0YSI6eyJ0YWJsZXQiOnt9LCJtb2JpbGUiOnt9fX0=&#8221; mobile_bg_img_hidden=&#8221;no&#8221; tablet_bg_img_hidden=&#8221;no&#8221; woodmart_parallax=&#8221;0&#8243; woodmart_gradient_switch=&#8221;no&#8221; woodmart_box_shadow=&#8221;no&#8221; wd_z_index=&#8221;no&#8221; woodmart_disable_overflow=&#8221;0&#8243; row_reverse_mobile=&#8221;0&#8243; row_reverse_tablet=&#8221;0&#8243;][vc_column]<div id=\"6afbda2933130\" class=\"wd-blog-element wd-rs-6a6c53cd9dee5 wd-wpb\"><div class=\"wd-posts wd-blog-holder wd-grid-g\" data-paged=\"1\" data-atts=\"{&quot;carousel_id&quot;:&quot;5000&quot;,&quot;speed&quot;:&quot;5000&quot;,&quot;slides_per_view&quot;:&quot;3&quot;,&quot;slides_per_view_tablet&quot;:&quot;auto&quot;,&quot;slides_per_view_mobile&quot;:&quot;auto&quot;,&quot;wrap&quot;:&quot;&quot;,&quot;loop&quot;:false,&quot;autoplay&quot;:&quot;no&quot;,&quot;autoheight&quot;:&quot;no&quot;,&quot;hide_pagination_control&quot;:&quot;&quot;,&quot;hide_pagination_control_tablet&quot;:&quot;yes&quot;,&quot;hide_pagination_control_mobile&quot;:&quot;yes&quot;,&quot;dynamic_pagination_control&quot;:&quot;no&quot;,&quot;hide_prev_next_buttons&quot;:&quot;&quot;,&quot;hide_prev_next_buttons_tablet&quot;:&quot;&quot;,&quot;hide_prev_next_buttons_mobile&quot;:&quot;&quot;,&quot;carousel_arrows_position&quot;:&quot;&quot;,&quot;hide_scrollbar&quot;:&quot;yes&quot;,&quot;hide_scrollbar_tablet&quot;:&quot;yes&quot;,&quot;hide_scrollbar_mobile&quot;:&quot;yes&quot;,&quot;scroll_per_page&quot;:&quot;yes&quot;,&quot;dragEndSpeed&quot;:200,&quot;center_mode&quot;:&quot;no&quot;,&quot;custom_sizes&quot;:&quot;&quot;,&quot;sliding_speed&quot;:false,&quot;animation&quot;:false,&quot;content_animation&quot;:false,&quot;post_type&quot;:&quot;post&quot;,&quot;slider&quot;:&quot;&quot;,&quot;library&quot;:&quot;&quot;,&quot;css&quot;:&quot;&quot;,&quot;effect&quot;:&quot;&quot;,&quot;spacing&quot;:&quot;&quot;,&quot;spacing_tablet&quot;:&quot;&quot;,&quot;spacing_mobile&quot;:&quot;&quot;,&quot;carousel_sync&quot;:&quot;&quot;,&quot;sync_parent_id&quot;:&quot;&quot;,&quot;sync_child_id&quot;:&quot;&quot;,&quot;sync_group_id&quot;:&quot;group-1&quot;,&quot;scroll_carousel_init&quot;:&quot;no&quot;,&quot;disable_overflow_carousel&quot;:&quot;no&quot;,&quot;include&quot;:&quot;&quot;,&quot;custom_query&quot;:&quot;&quot;,&quot;taxonomies&quot;:&quot;221&quot;,&quot;pagination&quot;:&quot;pagination&quot;,&quot;parts_media&quot;:true,&quot;parts_title&quot;:&quot;1&quot;,&quot;parts_meta&quot;:&quot;0&quot;,&quot;parts_text&quot;:&quot;1&quot;,&quot;parts_btn&quot;:&quot;1&quot;,&quot;parts_published_date&quot;:&quot;0&quot;,&quot;items_per_page&quot;:12,&quot;offset&quot;:&quot;&quot;,&quot;orderby&quot;:&quot;date&quot;,&quot;order&quot;:&quot;DESC&quot;,&quot;meta_key&quot;:&quot;&quot;,&quot;exclude&quot;:&quot;&quot;,&quot;class&quot;:&quot;&quot;,&quot;ajax_page&quot;:&quot;&quot;,&quot;img_size&quot;:&quot;300x220&quot;,&quot;img_size_custom&quot;:[],&quot;blog_design&quot;:&quot;meta-image&quot;,&quot;blog_masonry&quot;:false,&quot;blog_carousel_design&quot;:&quot;masonry&quot;,&quot;blog_columns&quot;:3,&quot;blog_columns_tablet&quot;:&quot;auto&quot;,&quot;blog_columns_mobile&quot;:&quot;auto&quot;,&quot;blog_spacing&quot;:&quot;30&quot;,&quot;blog_spacing_tablet&quot;:&quot;&quot;,&quot;blog_spacing_mobile&quot;:&quot;30&quot;,&quot;lazy_loading&quot;:&quot;no&quot;,&quot;search&quot;:&quot;&quot;,&quot;woodmart_css_id&quot;:&quot;6a6c53cd9dee5&quot;,&quot;element_title&quot;:&quot;&quot;,&quot;element_title_tag&quot;:&quot;h3&quot;,&quot;inner_content&quot;:&quot;&quot;,&quot;el_id&quot;:&quot;&quot;,&quot;el_class&quot;:&quot;&quot;,&quot;wrapper_classes&quot;:&quot;&quot;}\" data-source=\"shortcode\" style=\"--wd-col-lg:3;--wd-col-md:3;--wd-col-sm:1;--wd-gap-lg:30px;--wd-gap-sm:30px;\">\n<article id=\"post-17861\" class=\"wd-post blog-design-meta-image blog-post-loop blog-style-flat wd-col post-17861 post type-post status-publish format-standard has-post-thumbnail hentry category-investor-zone category-media-reports category-new-drug-development-and-regulation\">\n\t\n\t<div class=\"wd-post-thumb color-scheme-light\">\n\t\t\t\t\t<div class=\"wd-post-img\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"220\" src=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/01\/Group-245-300x220.png\" class=\"attachment-300x220 size-300x220\" alt=\"\" title=\"\">\t\t\t<\/div>\n\t\t\n\t\t\t\t<a class=\"wd-post-link wd-fill\" tabindex=\"-1\" href=\"https:\/\/u-neuron.com\/en\/yonglirongs-new-amniotic-fluid-stem-cell-drug-received-dual-fast-track-certification-for-regenerative-medicine\/\" rel=\"bookmark\" aria-label=\"Link on post U-NEURON&#8217;s Amniotic Fluid Stem Cell New Drug Secures Dual ExpeditedRegulatory Guidance for Regenerative Medicine\"><\/a>\n\n\t\t\t<\/div>\n\n\t<div class=\"wd-post-content\">\n\t\t<div class=\"wd-post-meta wd-post-entry-meta\">\n\t\t\t\n\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<h3 class=\"wd-post-title wd-entities-title title post-title\">\n\t\t\t\t<a href=\"https:\/\/u-neuron.com\/en\/yonglirongs-new-amniotic-fluid-stem-cell-drug-received-dual-fast-track-certification-for-regenerative-medicine\/\" rel=\"bookmark\">\n\t\t\t\t\tU-NEURON&#8217;s Amniotic Fluid Stem Cell New Drug Secures Dual ExpeditedRegulatory Guidance for Regenerative Medicine\t\t\t\t<\/a>\n\t\t\t<\/h3>\n\t\t\n\t\t\t\t\t<div class=\"wd-post-excerpt\">\n\t\t\t\t\t\t\t\t\tU-NEURON (6973-TW) announced today (22nd) that its proprietary new drug candidate UA002, designed for the treatment of erectile dysfunction, has been approved by Taiwan TFDA under the \"Project-Based Advisory and Guidance Cases\" scheme. Concurrently, UA002 secured the \"Flagship Project\" (Index Case) qualification from the Center for Drug Evaluation (CDE). Under this dedicated advisory framework, the company expects to accelerate development and regulatory review while mitigating R&amp;D risks, marking dual expeditedregulatory support in the regenerative medicine arena.\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"wd-post-read-more wd-style-link read-more-section\">\n\t\t\t\t\t\t<a class=\"\" href=\"https:\/\/u-neuron.com\/en\/yonglirongs-new-amniotic-fluid-stem-cell-drug-received-dual-fast-track-certification-for-regenerative-medicine\/\">Continue reading<\/a>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\n\t<\/article>\n\n<article id=\"post-17864\" class=\"wd-post blog-design-meta-image blog-post-loop blog-style-flat wd-col post-17864 post type-post status-publish format-standard has-post-thumbnail hentry category-investor-zone category-media-reports category-new-drug-development-and-regulation\">\n\t\n\t<div class=\"wd-post-thumb color-scheme-light\">\n\t\t\t\t\t<div class=\"wd-post-img\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"220\" src=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/5af5da18-8cd3-4ba6-8a0e-f6cdfc639a77-w2400-300x220.webp\" class=\"attachment-300x220 size-300x220\" alt=\"\" title=\"\">\t\t\t<\/div>\n\t\t\n\t\t\t\t<a class=\"wd-post-link wd-fill\" tabindex=\"-1\" href=\"https:\/\/u-neuron.com\/en\/yonglirong-attacks-the-tens-of-billions-of-ed-blue-ocean-market-opportunities-and-launches-a-comprehensive-health-and-beauty-engine\/\" rel=\"bookmark\" aria-label=\"Link on post U-NEURON Targets Multi-Billion ED Blue Ocean Market, Launching Dual-Engine Growth in Healthcare and Aesthetics\"><\/a>\n\n\t\t\t<\/div>\n\n\t<div class=\"wd-post-content\">\n\t\t<div class=\"wd-post-meta wd-post-entry-meta\">\n\t\t\t\n\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<h3 class=\"wd-post-title wd-entities-title title post-title\">\n\t\t\t\t<a href=\"https:\/\/u-neuron.com\/en\/yonglirong-attacks-the-tens-of-billions-of-ed-blue-ocean-market-opportunities-and-launches-a-comprehensive-health-and-beauty-engine\/\" rel=\"bookmark\">\n\t\t\t\t\tU-NEURON Targets Multi-Billion ED Blue Ocean Market, Launching Dual-Engine Growth in Healthcare and Aesthetics\t\t\t\t<\/a>\n\t\t\t<\/h3>\n\t\t\n\t\t\t\t\t<div class=\"wd-post-excerpt\">\n\t\t\t\t\t\t\t\t\tU-NEURON Chairman Dr. Frank Chien Projects Turnaround to Profitability Next Year\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"wd-post-read-more wd-style-link read-more-section\">\n\t\t\t\t\t\t<a class=\"\" href=\"https:\/\/u-neuron.com\/en\/yonglirong-attacks-the-tens-of-billions-of-ed-blue-ocean-market-opportunities-and-launches-a-comprehensive-health-and-beauty-engine\/\">Continue reading<\/a>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\n\t<\/article>\n\n<article id=\"post-17868\" class=\"wd-post blog-design-meta-image blog-post-loop blog-style-flat wd-col post-17868 post type-post status-publish format-standard has-post-thumbnail hentry category-investor-zone category-media-reports category-new-drug-development-and-regulation\">\n\t\n\t<div class=\"wd-post-thumb color-scheme-light\">\n\t\t\t\t\t<div class=\"wd-post-img\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"220\" src=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-300x220.webp\" class=\"attachment-300x220 size-300x220\" alt=\"\" title=\"\">\t\t\t<\/div>\n\t\t\n\t\t\t\t<a class=\"wd-post-link wd-fill\" tabindex=\"-1\" href=\"https:\/\/u-neuron.com\/en\/the-first-patent-for-amniotic-fluid-stem-cells-targeting-tens-of-billions-of-impotence-wealth-chairman-yong-lirong-those-who-are-dissatisfied-with-viagra-are-all-our-customers\/\" rel=\"bookmark\" aria-label=\"Link on post Pioneering Patented Amniotic Fluid Stem Cell Technology! Targeting a Multi-Billion-Dollar Market, U-NEURON Chairman States: &#8220;Anyone Dissatisfied with Viagra Is Our Customer&#8221;\"><\/a>\n\n\t\t\t<\/div>\n\n\t<div class=\"wd-post-content\">\n\t\t<div class=\"wd-post-meta wd-post-entry-meta\">\n\t\t\t\n\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<h3 class=\"wd-post-title wd-entities-title title post-title\">\n\t\t\t\t<a href=\"https:\/\/u-neuron.com\/en\/the-first-patent-for-amniotic-fluid-stem-cells-targeting-tens-of-billions-of-impotence-wealth-chairman-yong-lirong-those-who-are-dissatisfied-with-viagra-are-all-our-customers\/\" rel=\"bookmark\">\n\t\t\t\t\tPioneering Patented Amniotic Fluid Stem Cell Technology! Targeting a Multi-Billion-Dollar Market, U-NEURON Chairman States: &#8220;Anyone Dissatisfied with Viagra Is Our Customer&#8221;\t\t\t\t<\/a>\n\t\t\t<\/h3>\n\t\t\n\t\t\t\t\t<div class=\"wd-post-excerpt\">\n\t\t\t\t\t\t\t\t\tU-NEURON (6973) leverages its world-leading patented amniotic fluid stem cell technology to address the multi-billion-dollar blue ocean market of male erectile dysfunction (ED).\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"wd-post-read-more wd-style-link read-more-section\">\n\t\t\t\t\t\t<a class=\"\" href=\"https:\/\/u-neuron.com\/en\/the-first-patent-for-amniotic-fluid-stem-cells-targeting-tens-of-billions-of-impotence-wealth-chairman-yong-lirong-those-who-are-dissatisfied-with-viagra-are-all-our-customers\/\">Continue reading<\/a>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\n\t<\/article>\n\n<article id=\"post-17898\" class=\"wd-post blog-design-meta-image blog-post-loop blog-style-flat wd-col post-17898 post type-post status-publish format-standard has-post-thumbnail hentry category-investor-zone category-media-reports category-new-drug-development-and-regulation\">\n\t\n\t<div class=\"wd-post-thumb color-scheme-light\">\n\t\t\t\t\t<div class=\"wd-post-img\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"220\" src=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/01\/Group-245-300x220.png\" class=\"attachment-300x220 size-300x220\" alt=\"\" title=\"\">\t\t\t<\/div>\n\t\t\n\t\t\t\t<a class=\"wd-post-link wd-fill\" tabindex=\"-1\" href=\"https:\/\/u-neuron.com\/en\/yonglirongs-new-erectile-dysfunction-drug-ua002-passed-clinical-phase-i-safety-verification\/\" rel=\"bookmark\" aria-label=\"Link on post U-NEURON&#8217;s ED Drug UA002 Validates Phase 1 Safety Profile\"><\/a>\n\n\t\t\t<\/div>\n\n\t<div class=\"wd-post-content\">\n\t\t<div class=\"wd-post-meta wd-post-entry-meta\">\n\t\t\t\n\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<h3 class=\"wd-post-title wd-entities-title title post-title\">\n\t\t\t\t<a href=\"https:\/\/u-neuron.com\/en\/yonglirongs-new-erectile-dysfunction-drug-ua002-passed-clinical-phase-i-safety-verification\/\" rel=\"bookmark\">\n\t\t\t\t\tU-NEURON&#8217;s ED Drug UA002 Validates Phase 1 Safety Profile\t\t\t\t<\/a>\n\t\t\t<\/h3>\n\t\t\n\t\t\t\t\t<div class=\"wd-post-excerpt\">\n\t\t\t\t\t\t\t\t\tU-NEURON (6973), a biotech companylistedon Taiwan\u2019s Emerging Stock Market, announced on the 3rd that Phase 1 clinical trial enrollment for its novel therapeutic UA002, targeting male erectile dysfunction (ED), has been completed, with Phase 2 trials set to commence.\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"wd-post-read-more wd-style-link read-more-section\">\n\t\t\t\t\t\t<a class=\"\" href=\"https:\/\/u-neuron.com\/en\/yonglirongs-new-erectile-dysfunction-drug-ua002-passed-clinical-phase-i-safety-verification\/\">Continue reading<\/a>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\n\t<\/article>\n\n<article id=\"post-17911\" class=\"wd-post blog-design-meta-image blog-post-loop blog-style-flat wd-col post-17911 post type-post status-publish format-standard has-post-thumbnail hentry category-latest-news category-event-and-exhibition-information category-new-drug-development-and-regulation\">\n\t\n\t<div class=\"wd-post-thumb color-scheme-light\">\n\t\t\t\t\t<div class=\"wd-post-img\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"220\" src=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/01\/Rectangle-25-300x220.png\" class=\"attachment-300x220 size-300x220\" alt=\"\" title=\"\">\t\t\t<\/div>\n\t\t\n\t\t\t\t<a class=\"wd-post-link wd-fill\" tabindex=\"-1\" href=\"https:\/\/u-neuron.com\/en\/yonglirong-biomedicals-ua002-bio-japan-debuted-before-the-exhibition-stunning-the-world\/\" rel=\"bookmark\" aria-label=\"Link on post U-NEURON Biomedical Presented UA002 Ahead of BioJapan, Impressing International Stakeholders\"><\/a>\n\n\t\t\t<\/div>\n\n\t<div class=\"wd-post-content\">\n\t\t<div class=\"wd-post-meta wd-post-entry-meta\">\n\t\t\t\n\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<h3 class=\"wd-post-title wd-entities-title title post-title\">\n\t\t\t\t<a href=\"https:\/\/u-neuron.com\/en\/yonglirong-biomedicals-ua002-bio-japan-debuted-before-the-exhibition-stunning-the-world\/\" rel=\"bookmark\">\n\t\t\t\t\tU-NEURON Biomedical Presented UA002 Ahead of BioJapan, Impressing International Stakeholders\t\t\t\t<\/a>\n\t\t\t<\/h3>\n\t\t\n\t\t\t\t\t<div class=\"wd-post-excerpt\">\n\t\t\t\t\t\t\t\t\tRegenerative medicine company U-NEURON Biomedical presented its proprietary amniotic fluid stem cell drug candidate UA002 during the Link-J roadshow session prior to BioJapan on October 7. BioJapan is Asia's flagship medical exhibition, serving as an ideal platform for regenerative medicine. The Link-J Global Life Science Session brought together participants from over 10 countries across the Americas, Japan, Europe, Asia, and Australia. Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) of the Ministry of Economic Affairs, the delegation introduced top-performing Taiwanese biomedical companies during the international roadshow.\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"wd-post-read-more wd-style-link read-more-section\">\n\t\t\t\t\t\t<a class=\"\" href=\"https:\/\/u-neuron.com\/en\/yonglirong-biomedicals-ua002-bio-japan-debuted-before-the-exhibition-stunning-the-world\/\">Continue reading<\/a>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\n\t<\/article>\n<\/div><\/div>[\/vc_column][\/vc_row][\/vc_section]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_section woodmart_stretch_content=&#8221;section-stretch-content&#8221; css=&#8221;.vc_custom_1769600714167{margin-top: -70px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}&#8221; woodmart_css_id=&#8221;6979f6af2f435&#8243; responsive_spacing=&#8221;eyJwYXJhbV90eXBlIjoid29vZG1hcnRfcmVzcG9uc2l2ZV9zcGFjaW5nIiwic2VsZWN0b3JfaWQiOiI2OTc5ZjZhZjJmNDM1Iiwic2hvcnRjb2RlIjoidmNfc2VjdGlvbiIsImRhdGEiOnsidGFibGV0Ijp7fSwibW9iaWxlIjp7fX19&#8243; mobile_bg_img_hidden=&#8221;no&#8221; tablet_bg_img_hidden=&#8221;no&#8221; woodmart_parallax=&#8221;0&#8243;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":18415,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-17937","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/pages\/17937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/comments?post=17937"}],"version-history":[{"count":11,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/pages\/17937\/revisions"}],"predecessor-version":[{"id":18625,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/pages\/17937\/revisions\/18625"}],"up":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/pages\/18415"}],"wp:attachment":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/media?parent=17937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}